Home > Research > Publications & Outputs > Activation of the Abelson tyrosine kinase activ...
View graph of relations

Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells

Research output: Contribution to journalJournal articlepeer-review

Published

Standard

Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells. / Evans, C A; Owen-Lynch, P J; Whetton, A D; Dive, C.

In: Cancer Research, Vol. 53, No. 8, 15.04.1993, p. 1735-1738.

Research output: Contribution to journalJournal articlepeer-review

Harvard

APA

Vancouver

Evans CA, Owen-Lynch PJ, Whetton AD, Dive C. Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells. Cancer Research. 1993 Apr 15;53(8):1735-1738.

Author

Evans, C A ; Owen-Lynch, P J ; Whetton, A D ; Dive, C. / Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells. In: Cancer Research. 1993 ; Vol. 53, No. 8. pp. 1735-1738.

Bibtex

@article{9e4d33a35e20441e98c215657c36ea93,
title = "Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells",
abstract = "A chromosomal translocation uniquely associated with chronic myeloid leukemia leads to the formation of a chimeric gene, bcr-abl, on the Philadelphia chromosome. The BRC-ABL protein displays an uncontrolled tyrosine kinase activity similar to that seen with the transforming oncogene of the Abelson murine leukemia (ABL) virus (v-abl). An interleukin 3 dependent cell line, IC.DP, has been transfected with a gene encoding a temperature sensitive v-ABL. In the absence of interleukin 3 at the restrictive temperature for ABL tyrosine kinase activity IC.DP cells died via apoptosis. At the permissive temperature ABL tyrosine kinase activity promoted IC.DP cell survival but not proliferation. ABL therefore can specifically suppress apoptosis.",
author = "Evans, {C A} and Owen-Lynch, {P J} and Whetton, {A D} and C Dive",
year = "1993",
month = apr,
day = "15",
language = "English",
volume = "53",
pages = "1735--1738",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

RIS

TY - JOUR

T1 - Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells

AU - Evans, C A

AU - Owen-Lynch, P J

AU - Whetton, A D

AU - Dive, C

PY - 1993/4/15

Y1 - 1993/4/15

N2 - A chromosomal translocation uniquely associated with chronic myeloid leukemia leads to the formation of a chimeric gene, bcr-abl, on the Philadelphia chromosome. The BRC-ABL protein displays an uncontrolled tyrosine kinase activity similar to that seen with the transforming oncogene of the Abelson murine leukemia (ABL) virus (v-abl). An interleukin 3 dependent cell line, IC.DP, has been transfected with a gene encoding a temperature sensitive v-ABL. In the absence of interleukin 3 at the restrictive temperature for ABL tyrosine kinase activity IC.DP cells died via apoptosis. At the permissive temperature ABL tyrosine kinase activity promoted IC.DP cell survival but not proliferation. ABL therefore can specifically suppress apoptosis.

AB - A chromosomal translocation uniquely associated with chronic myeloid leukemia leads to the formation of a chimeric gene, bcr-abl, on the Philadelphia chromosome. The BRC-ABL protein displays an uncontrolled tyrosine kinase activity similar to that seen with the transforming oncogene of the Abelson murine leukemia (ABL) virus (v-abl). An interleukin 3 dependent cell line, IC.DP, has been transfected with a gene encoding a temperature sensitive v-ABL. In the absence of interleukin 3 at the restrictive temperature for ABL tyrosine kinase activity IC.DP cells died via apoptosis. At the permissive temperature ABL tyrosine kinase activity promoted IC.DP cell survival but not proliferation. ABL therefore can specifically suppress apoptosis.

M3 - Journal article

C2 - 8467488

VL - 53

SP - 1735

EP - 1738

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 8

ER -